Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study assessing pharmacokinetics and safety of BR1019 alone and in combination with BR1019-3 and BR1019-2 in healthy volunteers; the trial has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• BR1019
• BR1019-2
• BR1019-3

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Essential Hypertension, Type 2 Diabetes | Phase 1 | Status: COMPLETED